NO972303L - Intravenöse lubeluzollösninger - Google Patents

Intravenöse lubeluzollösninger

Info

Publication number
NO972303L
NO972303L NO972303A NO972303A NO972303L NO 972303 L NO972303 L NO 972303L NO 972303 A NO972303 A NO 972303A NO 972303 A NO972303 A NO 972303A NO 972303 L NO972303 L NO 972303L
Authority
NO
Norway
Prior art keywords
lubeluzole
intravenous
solutions
solution
adjust
Prior art date
Application number
NO972303A
Other languages
English (en)
Other versions
NO972303D0 (no
Inventor
Marc Karel Jozef Francois
Jozef Peeters
Christiane Gabriella Ger Hayns
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO972303L publication Critical patent/NO972303L/no
Publication of NO972303D0 publication Critical patent/NO972303D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En løsning for intravenøs administrasjon innehol- dende lubeluzol eller et farmasøytisk akseptabelt addisjonssalt derav, et isotoniseringsmiddel, vann og syre og basesubstanser for å innstille pH-verdi- en i løsningen i området fra 2,5 til 3,6; fremgangsmåter ved deres fremstilling.
NO972303A 1994-11-24 1997-05-21 Intravenöse lubeluzollösninger NO972303D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203422 1994-11-24
PCT/EP1995/004520 WO1996015790A1 (en) 1994-11-24 1995-11-16 Lubeluzole intravenous solutions

Publications (2)

Publication Number Publication Date
NO972303L true NO972303L (no) 1997-05-21
NO972303D0 NO972303D0 (no) 1997-05-21

Family

ID=8217408

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972303A NO972303D0 (no) 1994-11-24 1997-05-21 Intravenöse lubeluzollösninger

Country Status (19)

Country Link
US (1) US5744484A (no)
EP (1) EP0794777A1 (no)
JP (1) JPH10509712A (no)
CN (1) CN1166787A (no)
AR (1) AR002001A1 (no)
AU (1) AU693969B2 (no)
BR (1) BR9509821A (no)
CA (1) CA2205606A1 (no)
CZ (1) CZ155897A3 (no)
FI (1) FI972204A0 (no)
HU (1) HUT77390A (no)
IL (1) IL116102A (no)
MX (1) MX9703839A (no)
NO (1) NO972303D0 (no)
PL (1) PL320296A1 (no)
SK (1) SK65197A3 (no)
TR (1) TR199501482A1 (no)
WO (1) WO1996015790A1 (no)
ZA (1) ZA959995B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
WO1997015306A1 (en) * 1995-10-25 1997-05-01 Janssen Pharmaceutica N.V. Infusions of neuroprotectants and perfluorochemicals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
CZ155897A3 (en) 1997-10-15
AU693969B2 (en) 1998-07-09
CA2205606A1 (en) 1996-05-30
EP0794777A1 (en) 1997-09-17
FI972204A (fi) 1997-05-23
JPH10509712A (ja) 1998-09-22
TR199501482A1 (tr) 1996-10-21
FI972204A0 (fi) 1997-05-23
AR002001A1 (es) 1998-01-07
CN1166787A (zh) 1997-12-03
WO1996015790A1 (en) 1996-05-30
BR9509821A (pt) 1997-10-21
ZA959995B (en) 1997-05-23
AU4172996A (en) 1996-06-17
MX9703839A (es) 1997-08-30
IL116102A (en) 2000-02-29
SK65197A3 (en) 1997-12-10
US5744484A (en) 1998-04-28
PL320296A1 (en) 1997-09-15
IL116102A0 (en) 1996-01-31
HUT77390A (hu) 1998-04-28
NO972303D0 (no) 1997-05-21

Similar Documents

Publication Publication Date Title
NO20054324L (no) Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning
LU90297I2 (fr) Rivastigmine ses sels et dérivés pharmaceutiquement acceptables en particulier la rivastigmine sous forme d'hydrogénotartrate
CA2201749A1 (en) Stable aqueous alfa interferon solution formulations
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
IL128036A (en) Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereof
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE9503143D0 (sv) New preparation
UA42779C2 (uk) Фармацевтично стійкий препарат оксалату платини для парентерального застосування
ATE153022T1 (de) 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
DK146786A (da) 4'-demethyl-4-epipodophyllotoxinderivater, deres fremstilling og anvendelse i laegemidler, isaer som antitumormidler
DE69631542D1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA2000336A1 (en) Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
EP0800828A4 (en) TRANSMUCOSAL PREPARATION
NO972303L (no) Intravenöse lubeluzollösninger
IE802033L (en) Dibenzazepine derivatives
ATE117313T1 (de) Stabile lösungen von rebeccamycinderivaten sowie deren herstellung.
WO1990003172A3 (en) Bile acids for treatment of viral infections
KR830004849A (ko) 약학적 제제의 제조방법
KR860002269A (ko) 비경구용 액제의 제조방법
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
KR900004713A (ko) 디아민 유도체 및 그의 제조방법
Senczuk et al. Toxicodynamic properties of toluidines. Part V. Methaemoglobin-genic action of toluidines.
RU98114539A (ru) Способ создания модели экспериментальной глаукомы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application